Author + information
Waters DD, Ho JE, Boekholdt SM, DeMicco DA, Kastelein JJP, Messig M, Breazna A, Pedersen TR.
Cardiovascular Event Reduction Versus New-Onset Diabetes During Atorvastatin Therapy: Effect of Baseline Risk Factors for Diabetes.
J Am Coll Cardiol 2013;61:148–52.
Page 149, Methods section, 2nd paragraph: “FBG was measured at each 6-month visit in both TNT and IDEAL trials.”
should have read:
“In the TNT trial FBG was measured at randomization and each annual visit. The IDEAL protocol mandated FBG measurements only at randomization and the end-of-study visit. Some investigators collected FBG at additional time-points and that data was included in our analysis.”
The authors apologize for this error.
- American College of Cardiology Foundation